- Home
- DSL vs IRMD Comparison
DSL vs IRMD Comparison
Compare DSL & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DSL | IRMD |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | DSL | IRMD |
|---|---|---|
| Price | $11.49 | $99.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 600.1K | 51.0K |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | ★ 11.51% | 0.79% |
| EPS Growth | N/A | ★ 11.11 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $73,242,121.00 |
| Revenue This Year | N/A | $11.99 |
| Revenue Next Year | N/A | $9.91 |
| P/E Ratio | ★ N/A | $80.71 |
| Revenue Growth | N/A | ★ 11.71 |
| 52 Week Low | $10.58 | $47.48 |
| 52 Week High | $12.91 | $107.90 |
Technical Indicators
Market Signals| Indicator | DSL | IRMD |
|---|---|---|
| Relative Strength Index (RSI) | 44.75 | 50.82 |
| Support Level | $11.10 | $92.51 |
| Resistance Level | $11.41 | $106.42 |
| Average True Range (ATR) | 0.07 | 3.59 |
| MACD | -0.01 | 0.09 |
| Stochastic Oscillator | 3.39 | 46.05 |
Price Performance
Historical ComparisonAbout DSL DoubleLine Income Solutions Fund of Beneficial Interests
DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.